Common use of Safe Harbor Statement Clause in Contracts

Safe Harbor Statement. Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with the anticipated benefits of our agreement with Merck KGaA, and our ability to support the development, regulatory filing and commercialization of companion diagnostics. Words such as “believes,” “anticipates,” “plans,” “expects,” “intends,” “will,” “goal,” “potential,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements necessarily contain these identifying words. These forward-looking statements are based upon management’s current expectations, are subject to known and unknown risks, and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, including, without limitation, the risk that we may not realize the expected benefits from our agreement with Merck KGaA, risks associated with the utility of our automation systems, proprietary profiling panels and solutions, and our ability to successfully manufacture and supply our products. These and other factors are described in greater detail in our filings with the Securities and Exchange Commission, including, without limitation, our Quarterly Report on Form 10-Q for the quarter ended June 30, 2016. All forward-looking statements contained in this press release speak only as of the date on which they were made, and we undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Safe Harbor Statement. Statements contained in this This press release regarding matters that are not historical facts are “contains forward-looking statements” statements within the meaning of Section 27A of the Private Securities Litigation Reform Act of 19951933, including statements associated with the anticipated benefits of our agreement with Merck KGaAas amended, and our ability to support Section 21E of the developmentSecurities Exchange and Exchange Act of 1934, regulatory filing and commercialization of companion diagnostics. Words such as “believes,” “anticipates,” “plans,” “expects,” “intends,” “will,” “goal,” “potential,” and similar expressions amended, that are intended to identify be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, though not all forward-looking statements necessarily contain these identifying words. These forward-looking statements are based upon management’s current expectations, are subject to known and unknown risks, and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various factors including those risks and uncertainties, including, without limitation, uncertainties described in the risk that we may not realize the expected benefits from our agreement with Merck KGaA, risks associated with the utility Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our automation systems, proprietary profiling panels and solutions, and our ability to successfully manufacture and supply our products. These and other factors are described in greater detail in our filings with the Securities and Exchange Commission, including, without limitation, our Quarterly Report recently filed registration statement on Form 10-Q for the quarter ended June 30, 2016S-1. All We urge you to consider those risks and uncertainties in evaluating our forward-looking statements contained in this press release speak only as of the date on which they were made, and we undertake no obligation statements. We caution readers not to update place undue reliance upon any such statements to reflect events that occur or circumstances that exist after the date on which they were made.forward-looking statements,

Safe Harbor Statement. Statements contained Certain matters discussed in this press release regarding matters that are not historical facts are “forward-looking statements” within intended to qualify for the meaning of safe harbor from liability established by the Private Securities Litigation Reform Act of 1995, including . These forward-looking statements associated with may generally be identified as such because the anticipated benefits context of our agreement with Merck KGaA, and our ability to support the development, regulatory filing and commercialization of companion diagnostics. Words such statements will include words such as “believesanticipate,” “anticipatesbelieve,” “planscould,” “expectsestimate,” “intendsexpect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “goal,would” “potential,” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and similar expressions uncertainties that could cause results to differ materially from those expected. Shareholders, potential investors and other readers are intended urged to identify consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this press release and we undertake no obligation to publicly update any forward-looking statements, though not all forward-looking statements necessarily contain these identifying words. These forward-looking statements are based upon management’s current expectations, are subject to known and unknown risks, and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements whether as a result of various risks and uncertaintiesnew information, including, without limitation, the risk future events or otherwise. More detailed information about factors that we may not realize the expected benefits from affect our agreement with Merck KGaA, risks associated with the utility of our automation systems, proprietary profiling panels and solutions, and our ability to successfully manufacture and supply our products. These and other factors are described in greater detail performance may be found in our filings with the Securities and Exchange Commission, including, without limitation, our Quarterly Report on Form 10-Q for the quarter ended June 30, 2016. All forward-looking statements contained in this press release speak only as of the date on which they were made, and we undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.and

Safe Harbor Statement. Statements contained in this press release regarding matters This announcement contains statements that are not historical facts are may constitute “forward-looking statementslooking” within statements pursuant to the meaning “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995, including . These forward-looking statements associated with the anticipated benefits of our agreement with Merck KGaA, and our ability to support the development, regulatory filing and commercialization of companion diagnostics. Words can be identified by terminology such as “believeswill,” “expects,” “anticipates,” “plansaims,” “expectsfuture,” “intends,” “willplans,” “goalbelieves,” “potentialestimates,” “likely to,” and similar expressions statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in announcements and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are intended to identify not historical facts, including statements about the Company’s beliefs, plans, and expectations, are forward-looking statements, though not all forward. Forward-looking statements necessarily contain these identifying words. These forward-looking statements are based upon management’s current expectationsinvolve inherent risks and uncertainties, are subject to known and unknown risksincluding the possibility that a definitive agreement will not be concluded as contemplated under the collaboration agreement discussed in this announcement, and involve assumptions the possibility that may never the e-GOV system will not materialize as contemplated under the collaboration agreement or may prove a definitive agreement if and once concluded. A number of factors could also cause actual results to be incorrect. Actual results and the timing of events could differ materially from those anticipated contained in such any forward-looking statements as a result statement, including but not limited to the following: the Company’s strategies, future business development, and financial condition and results of various risks and uncertainties, including, without limitation, the risk that we may not realize operations; the expected benefits from our agreement with Merck KGaAgrowth of the digital solutions market; the political, risks associated with economic, social and legal developments in the utility of our automation systems, proprietary profiling panels jurisdictions that the Company operates in or in which the Company intends to expand its business and solutions, and our operations; the Company’s ability to successfully manufacture maintain and supply our productsenhance its brand. These Further information regarding these and other factors are described risks is included in greater detail in our the Company’s filings with the Securities and Exchange Commission, including, without limitation, our Quarterly Report on Form 10-Q for the quarter ended June 30, 2016SEC. All forward-looking statements contained information provided in this press release speak only announcement is as of the date on which they were madeof this announcement, and we the Company does not undertake no any obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were madeany forward-looking statement, except as required under applicable law.

Safe Harbor Statement. Statements contained in this This press release regarding matters that are not historical facts are “contains "forward-looking statements” " within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, including without limitation, statements associated with regarding the synergies between Spreadtrum and Tsinghua, positioning the Company’s business for continued growth, the increased intellectual property protection for the Company, the unlocking of hidden value, and other anticipated benefits of our agreement with Merck KGaA, and our ability to support the development, regulatory filing and commercialization of companion diagnosticsmerger for shareholders. Words such as “believesThe Company uses words like "believe,” “anticipates" "anticipate,” “plans" "intend,” “expects" "estimate,” “intends" "expect,” “will,” “goal,” “potential,” " "project" and similar expressions are intended to identify forward-looking statements, though although not all forward-looking statements necessarily contain these identifying words. These statements are forward-looking in nature and involve risks and uncertainties that may cause actual market trends and the Company's actual results to differ materially from those expressed or implied in these forward-looking statements for a variety of reasons. Potential risks and uncertainties include, but are based upon management’s current expectationsnot limited to, are subject to known and unknown risks, and involve assumptions that may never materialize or may prove to be incorrect. Actual results continuing competitive pressure in the semiconductor industry and the timing effect of events could differ materially such pressure on prices; unpredictable changes in technology and consumer demand for mobile phones; market acceptance of the Company’s smartphone products; transition trend from those anticipated 2.5G feature phones to smartphones; the state of and any change in the Company's relationship with its major domestic and international customers and Chinese government agencies; and changes in political, economic, legal and social conditions in China. For additional discussion of these risks and uncertainties and other factors, please consider the information contained in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC") and the annual report on Form 20-F filed on April 26, 2013 especially the section under "Risk Factors" and such other documents that the Company may file with the SEC from time to time, including on Form 6-K. The Company assumes no obligation to update any forward-looking statements as a result of various risks and uncertaintiesstatements, including, without limitation, the risk that we may not realize the expected benefits from our agreement with Merck KGaA, risks associated with the utility of our automation systems, proprietary profiling panels and solutions, and our ability to successfully manufacture and supply our products. These and other factors are described in greater detail in our filings with the Securities and Exchange Commission, including, without limitation, our Quarterly Report on Form 10-Q for the quarter ended June 30, 2016. All forward-looking statements contained in this press release speak which apply only as of the date on which they were madeof this press release, and we undertake no obligation does not intend to update such statements to reflect any forward-looking statement whether as a result of new information, future events that occur or circumstances that exist after the date on which they were madeotherwise except as required by law.